SAN
DIEGO, Oct. 25, 2022 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, announced today the Company will
release its third quarter financial results on Wednesday, November 9, 2022, after the market
close.
![NuVasive Logo NuVasive Logo](https://mma.prnewswire.com/media/454552/NuVasive_Logo.jpg)
NuVasive will hold a conference call on Wednesday,
November 9, 2022, at 4:30 p.m. ET / 1:30 p.m. PT to
discuss the results of its financial performance for the third
quarter ended September 30, 2022. The
dial-in numbers are 1-877-300-8521 for domestic callers and
1-412-317-6026 for international callers. A live webcast of the
conference call and supplemental financial information of our third
quarter 2022 results will be available on the Investor Relations
section of our website at www.nuvasive.com. An audio replay of
the call will be available until November 16, 2022. The replay
dial-in numbers are 1-844-512-2921 for domestic callers and
1-412-317-6671 for international callers. Please use pin number:
10172422. In addition, the webcast will be archived
on the Investor Relations section of NuVasive's
website.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine
technology innovation, with a mission to transform surgery, advance
care, and change lives. The Company's less-invasive, procedurally
integrated surgical solutions are designed to deliver reproducible
and clinically proven outcomes. The Company's comprehensive
procedural portfolio includes surgical access instruments, spinal
implants, fixation systems, biologics, software for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements included in this news
release and the associated conference call and webcast that are not
a description of historical facts are forward-looking statements
that involve risks, uncertainties, assumptions and other factors
which, if they do not materialize or prove correct, could
cause NuVasive's results to differ materially from
historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, but are not limited to, the risk
that NuVasive's net sales or earnings projections may
turn out to be inaccurate because of the preliminary nature of the
forecasts; the risk of further adjustment to financial results or
future financial expectations; unanticipated difficulty in selling
products, generating net sales or producing expected profitability;
and those other risks and uncertainties more fully described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-third-quarter-2022-results-301657552.html
SOURCE NuVasive, Inc.